C O Esquivel

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint Liver transplantation: where we are and where we are heading
    C O Esquivel
    Stanford University School of Medicine, Palo Alto, California, USA
    Transplant Proc 42:610-2. 2010
  2. ncbi request reprint Resection versus transplantation for hepatocellular carcinoma
    C O Esquivel
    Department of Surgery, Stanford University School of Medicine, California, USA
    J Gastroenterol Hepatol 14:S37-41. 1999
  3. ncbi request reprint Human hepatocytes produce an isoform of FAS that inhibits apoptosis
    S M Krams
    Department of Surgery, Stanford University School of Medicine, California 94305, USA
    Transplantation 65:713-21. 1998
  4. ncbi request reprint Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis?
    S K So
    Department of Surgery and Medicine, Stanford Asia Liver Center, Stanford University School of Medicine, California, USA
    J Gastroenterol Hepatol 14:S48-52. 1999
  5. doi request reprint PI3Kδ inhibition augments the efficacy of rapamycin in suppressing proliferation of Epstein-Barr virus (EBV)+ B cell lymphomas
    S Furukawa
    Division of Abdominal Transplantation, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA
    Am J Transplant 13:2035-43. 2013
  6. ncbi request reprint Apoptosis and allograft rejection in the absence of CD8+ T cells
    Y Ogura
    Transplant Immunobiology Laboratory, Department of Surgery, Stanford University School of Medicine, 1201 Welch Road, Stanford, CA 94305-5492, USA
    Transplantation 71:1827-34. 2001
  7. ncbi request reprint Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus
    S Cao
    Department of Surgery, Loma Linda University Medical Center, California 92354, USA
    Pediatr Transplant 3:22-6. 1999
  8. ncbi request reprint Liver transplantation in the first three months of life
    E S Woodle
    Department of Surgery, University of Chicago, Illinois 60637, USA
    Transplantation 66:606-9. 1998
  9. doi request reprint Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder
    O Hatton
    Program in Immunology, Department of Surgery Division of Abdominal Transplantation, Stanford University School of Medicine, Stanford, CA, USA
    Am J Transplant 13:883-90. 2013
  10. doi request reprint Acute rejection of small intestine allografts is associated with increased expression of toll-like receptors
    R O Castillo
    Lucile Packard Children s Hospital, Stanford University School of Medicine, Palo Alto, USA
    Transplant Proc 42:2676-8. 2010

Detail Information

Publications14

  1. doi request reprint Liver transplantation: where we are and where we are heading
    C O Esquivel
    Stanford University School of Medicine, Palo Alto, California, USA
    Transplant Proc 42:610-2. 2010
    ....
  2. ncbi request reprint Resection versus transplantation for hepatocellular carcinoma
    C O Esquivel
    Department of Surgery, Stanford University School of Medicine, California, USA
    J Gastroenterol Hepatol 14:S37-41. 1999
    ..This review will address the results observed following resection or transplantation for hepatocellular carcinoma...
  3. ncbi request reprint Human hepatocytes produce an isoform of FAS that inhibits apoptosis
    S M Krams
    Department of Surgery, Stanford University School of Medicine, California 94305, USA
    Transplantation 65:713-21. 1998
    ..The purpose of this study was to determine if soluble variants of Fas are produced in the liver and to determine if blockade of the Fas pathway, by liver-derived soluble Fas, inhibits Fas-mediated apoptosis...
  4. ncbi request reprint Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis?
    S K So
    Department of Surgery and Medicine, Stanford Asia Liver Center, Stanford University School of Medicine, California, USA
    J Gastroenterol Hepatol 14:S48-52. 1999
    ..The incidence of post-transplant HBV recurrence was similar: 0% in Asians compared with 7% in non-Asians. There was no recurrence in the group of 12 patients who were HBV-DNA or HBeAg negative pretransplant...
  5. doi request reprint PI3Kδ inhibition augments the efficacy of rapamycin in suppressing proliferation of Epstein-Barr virus (EBV)+ B cell lymphomas
    S Furukawa
    Division of Abdominal Transplantation, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA
    Am J Transplant 13:2035-43. 2013
    ....
  6. ncbi request reprint Apoptosis and allograft rejection in the absence of CD8+ T cells
    Y Ogura
    Transplant Immunobiology Laboratory, Department of Surgery, Stanford University School of Medicine, 1201 Welch Road, Stanford, CA 94305-5492, USA
    Transplantation 71:1827-34. 2001
    ..CONCLUSION: These data indicate that in the absence of CD8+ T cells an alternative pathway, associated with granzyme B and FasL expression and activation of the caspase cascade, can mediate apoptosis and graft rejection...
  7. ncbi request reprint Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus
    S Cao
    Department of Surgery, Loma Linda University Medical Center, California 92354, USA
    Pediatr Transplant 3:22-6. 1999
    ..However, the trade-off is a potential increased incidence of EBV-related PTLD in these patients...
  8. ncbi request reprint Liver transplantation in the first three months of life
    E S Woodle
    Department of Surgery, University of Chicago, Illinois 60637, USA
    Transplantation 66:606-9. 1998
    ..Although infants in the first 3 months of life have not traditionally been considered a distinct age group, several features of these infants may distinguish them from other pediatric liver transplant recipients...
  9. doi request reprint Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder
    O Hatton
    Program in Immunology, Department of Surgery Division of Abdominal Transplantation, Stanford University School of Medicine, Stanford, CA, USA
    Am J Transplant 13:883-90. 2013
    ..Taken together, our data indicate that Syk activates PI3K/Akt signaling which is required for survival of EBV+ B cell lymphomas. PI3K/Akt signaling may be a promising therapeutic target for PTLD, and other EBV-associated malignancies...
  10. doi request reprint Acute rejection of small intestine allografts is associated with increased expression of toll-like receptors
    R O Castillo
    Lucile Packard Children s Hospital, Stanford University School of Medicine, Palo Alto, USA
    Transplant Proc 42:2676-8. 2010
    ..These preliminary studies suggest an important role for in innate immune system in acute rejection of the small intestinal allografts, and as such represents an emerging and promising area of investigation...
  11. ncbi request reprint Major hepatic resection without blood transfusion: experience with total vascular exclusion
    S K So
    Department of Surgery, Stanford University School of Medicine, Stanford Asian Liver Center, California, USA
    J Gastroenterol Hepatol 14:S28-31. 1999
    ..It further obviates the need for dissection of the porta hepatis and its associated risks. Total vascular exclusion time of 30 min appears to be well tolerated, even in patients with compensated cirrhosis...
  12. ncbi request reprint Epstein-Barr virus infection is associated with endothelial Bcl-2 expression in transplant liver allografts
    M T Millan
    Department of Surgery, Division of Multi Organ Transplantation, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    Transplantation 73:465-9. 2002
    ..Bcl-2, an antiapoptotic factor induced by EBV in various host cells, is not normally expressed in the liver. We questioned whether bcl-2 is expressed in the transplanted liver and whether its expression is modified by EBV...
  13. ncbi request reprint Pediatric intestinal transplantation at Packard Children's Hospital/Stanford University Medical Center: report of a four-year experience
    R O Castillo
    Division of Gastroenterology, Nutrition and Liver Disease, Department of Pediatrics, Packard Children s Hospital, Palo Alto, CA 94304, USA
    Transplant Proc 38:1716-7. 2006
    ..Outcomes achieved levels expected based on The Intestinal Transplant Registry and UNOS criteria, which were better than expected for isolated intestinal transplants and achievement of enteral autonomy...
  14. ncbi request reprint Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling pathway
    A L Snow
    Program in Immunology and Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Immunol 167:5404-11. 2001
    ....